Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins

Bioconjugate Chemistry

Volumn 24, Issue 9, 2013, Pages 1584-1597

  Morlieras, Jessica ^a   Dufort, Sandrine ^b,c   Sancey, Lucie ^a   Truillet, Charles ^a   Mignot, Anna ^a,b,d   Rossetti, Fabien ^a   Dentamaro, Mario ^a,e   Laurent, Sophie ^e   Vander Elst, Luce ^e   Muller, Robert N ^e   Antoine, Rodolphe ^a   Dugourd, Philippe ^a   Roux, Stéphane ^f   Perriat, Pascal ^d   Lux, François ^a   Coll, Jean Luc ^c   Tillement, Olivier ^a  

^a UNIVERSITÉ LYON 1   (France)

^b Nano H SAS   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE LYON   (France)

^e UNIVERSITY OF MONS   (Belgium)

^f UNIVERSITÉ DE FRANCHE COMTÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENCE MICROSCOPY; GRAFTING (CHEMICAL); NANOPARTICLES; TUMORS;

CYCLIC PENTAPEPTIDES; FUNCTIONALIZATIONS; GADOLINIA; INTEGRINS; MULTIMODAL IMAGING; RADIO-SENSITIZATION; RGD MOTIF; RGD PEPTIDE; RGD SEQUENCES; TARGETING LIGANDS;

GLYCOPROTEINS;

ARGINYLGLYCYLASPARTIC ACID; CHEMICALS AND DRUGS; NANOPARTICLE; SMALL RIGID PARTICLE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; MOUSE; NEOPLASM; NONHUMAN; RADIOSENSITIZATION;

MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; FEMALE; HEK293 CELLS; HUMANS; INTEGRIN ALPHAVBETA3; MICE; MICE, NUDE; MOLECULAR IMAGING; NANOPARTICLES; NEOPLASMS; OPTICAL IMAGING; PEPTIDES, CYCLIC;

EID: 84884357912     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc4002097     Document Type: Article

References (49)

1. Cho, K., Wang, X., Nie, S., Chen, Z. G., and Shin, D. M. (2008) Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14, 1310-1316 (Pubitemid 351413909)
2. Davis, M. E., Chen, Z. G., and Shin, D. M. (2008) Nanoparticles Therapeutics: an emerging treatment modality for cancer Nat. Rev. Drug Discovery 7, 771-782
3. Ferrari, M. (2005) Cancer nanotechnology Nat. Rev. Cancer 5, 161-171
4. Jain, R. K. and Stylianopoulos, T. (2010) Delivering nanomedicine to solid tumors Nat. Rev. Clin. Oncol. 7, 653-664
5. Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., and Fuchs, H. (2009) Nanomedicine-Challenge and Perspectives Angew. Chem., Int. Ed. Engl. 48, 872-897
6. Hobbs, S. K., Monsky, W. L., Yuan, F., Roberts, W. G., Griffith, L., Torchilin, V., and Jain, R. K. (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment Proc. Natl. Acad. Sci. U. S. A. 95, 4607-4612 (Pubitemid 28207960)
7. Matsumura, Y. and Maeda, H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumirotropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46, 6387-6392 (Pubitemid 17221789)
8. Desgrosellier, J. S. and Cheresh, D. A. (2010) Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 10, 9-22
9. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., and Park, J. W. (2006) Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models Cancer Res. 66, 6732-6740 (Pubitemid 44085631)
10. Park, J. W., Benz, C. C., and Martin, F. J. (2004) Future directions of liposome- and immunoliposome- based cancer therapeutics Semin. Oncol. 31, 196-205 (Pubitemid 40023249)
11. Beer, A. J. and Schwaiger, M. (2008) Imaging of integrin alphavbeta3 expression Cancer Metastasis Rev. 27, 631-644
12. Beck, V., Herold, H., Benge, A., Luber, B., Hutzler, P., Tschesche, H., Kessler, H., Schmitt, M., Geppert, H. G., and Reuning, U. (2005) ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and mobility in an RGD-dependent fashion Int. J. Biochem. Cell Biol. 37, 590-603 (Pubitemid 40022936)
13. Chen, X., Liu, S., Hou, Y., Tohme, M., Park, R., Bading, J. R., and Conti, P. S. (2004) MicroPet imaging of breast cancer alphav-integrin expression with 64Cu-labeled dimeric RGD peptides Mol. Imaging Biol. 6, 350-359 (Pubitemid 39243068)
14. Ding, Q., Stewart, J., Jr., Olman, M. A., Klobe, M. R., and Gladson, C. L. (2003) The pattern of enhancement of Src kinase activity on platelet-derived growth factor simulation of glioblastoma cells is affected by the integrin engaged J. Biol. Chem. 278, 39882-39891 (Pubitemid 37248551)
15. Kuphal, S., Bauer, R., and Bosserhoff, A. K. (2005) Integrin signaling in malignant melanoma Cancer Metastasis Rev. 24, 195-222 (Pubitemid 40922795)
16. Hood, J. D. and Cheresh, D. A. (2002) Role of integrins in cell invasion and migration Nat. Rev. Cancer 2, 91-100 (Pubitemid 37328796)
17. Dobrucki, L. W., de Muinck, E. D., Lindner, J. R., and Sinusas, A. J. (2010) Approaches to multimodality imaging of angiogenesis J. Nucl. Med. 1 51 (Suppl 1) 66S-79S
18. Temming, K., Schiffelers, R. M., Molema, G., and Kok, R. J. (2005) RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature Drug Resist. Update 8, 381-402 (Pubitemid 43358061)
19. Schottelius, M., Laufer, B., Kessler, H., and Wester, H. J. (2009) Ligands for mapping alphavbeta3-integrin expression in vitro Acc. Chem. Res. 42, 969-980
20. Garanger, E., Boturyn, D., and Dumy, P. (2007) Tumor targetting with RGD peptide ligands-design of new molecular conjugates for imaging and therapy of cancer Anticancer Agents Med. Chem. 7, 552-558 (Pubitemid 351836126)
21. Liu, S. (2006) Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging Mol. Pharmaceutics 3, 472-487 (Pubitemid 44639125)
22. Chen, K., Xie, J., Xu, H., Behera, D., Michalski, M. H., Biswal, S., Wang, A., and Chen, X. (2009) Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting Biomaterials 30, 6912-6919
23. Zhang, F., Huang, X., Zhu, L., Guo, N., Niu, G., Swierczewska, M., Lee, S., Xu, H., Wang, A. Y., Mohamedali, K. A., Rosenblum, M. G., Lu, G., and Chen, X. (2012) Noninvasive monitoring of orthotopic glioblastoma therapy response using RGD-conjugated iron oxide nanoparticles Biomaterials 33, 5414-5422
24. Wadas, T. J., Deng, H., Sprague, J. E., Zheleznyak, A., Weilbaecher, K. N., and Anderson, C. J. (2009) Targeting the alphavbeta3 integrin for small-animal PET/CT of osteolytic bone metastases J. Nucl. Med. 50, 1873-1880
25. Haubner, R. and Decristoforo, C. (2009) Radiolabelled RGD peptides and peptidomimetics for tumour targeting Front. Biosci. 14, 872-886
26. Borden, M. A., Zhang, H., Gillies, R. J., Dayton, P. A., and Ferrara, K. W. (2008) A stimulus-responsive contrast agent for ultrasound molecular imaging Biomaterials 29, 597-606 (Pubitemid 350100802)
27. Goutayer, M., Dufort, S., Josserand, V., Royere, A., Heinrich, E., Vinet, F., Bibette, J., Coll, J. L., and Texier, I. (2010) Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging Eur. J. Pharm. Biopharm. 75, 137-147
28. Yong, K. T., Hu, R., Roy, I., Ding, H., Vathy, L. A., Bergey, E. J., Mizuma, M., Maitra, A., and Prasad, P. N. (2009) Tumor targeting and imaging in live animals with functionalized semiconductor quantum rods ACS Appl. Mater. Interfaces 1, 710-719
29. Borgman, M. P., Aras, O., Geyser-Stoops, S., Sausville, E. A., and Ghandehari, H. (2009) Biodistribution of HPMA copolymer-aminohexylgeldanamycin- RGDfK conjugates for prostate cancer drug delivery Mol. Pharmaceutics 6, 1836-1847
30. Han, H. D., Mangala, L. S., Lee, J. W., Shahzad, M. M., Kim, H. S., Shen, D., Nam, E. J., Mora, E. M., Stone, R. L., Lu, C., Lee, S. J., Roh, J. W., Nick, A. M., Lopez-Berestein, G., and Sood, A. K. (2010) Targeted gene silencing using RGD-labeled chitosan nanoparticles Clin. Cancer Res. 16, 3910-3922
31. Jiang, J., Yang, S., Wang, J. C., Yang, L. J., Xu, Z. Z., Yang, T., Liu, X. Y., and Zhang, Q. (2010) Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing Si-RNA or doxorubicin Eur. J. Pharm. Biopharm. 76, 170-178
32. Zhan, C., Gu, B., Xie, C., Li, J., Liu, Y., and Lu, W. (2010) Cyclix RGD conjugated poly(ethylen glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect J. Controlled Release 143, 136-142
33. Li, Z., Huang, P., Zhang, X., Lin, J., Yang, S., Liu, B., Gao, F., Xi, P., Ren, Q., and Cui, D. (2010) RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy Mol. Pharmaceutics 7, 94-104
34. Lux, F., Mignot, A., Mowat, P., Louis, C., Dufort, S., Bernhard, C., Denat, F., Boschetti, F., Brunet, C., Antoine, R., Dugourd, P., Laurent, S., Vander Elst, L., Muller, R., Sancey, L., Josserand, V., Coll, J. L., Stupar, V., Barbier, E., Remy, C., Broisat, A., Ghezzi, C., Le Duc, G., Roux, S., Perriat, P., and Tillement, O. (2011) Ultrasmall rigid particles as multimodal probes for medical applications Angew. Chem., Int. Ed. Engl. 50, 12299-12303
35. Le Duc, G., Miladi, I., Alric, C., Mowat, P., Brauer-Krisch, E., Bouchet, A., Khalil, E., Billotey, C., Janier, M., Lux, F., Epicier, T., Perriat, P., Roux, S., and Tillement, O. (2011) Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles ACS Nano 5, 9566-9574
36. Mowat, P., Mignot, A., Rima, W., Lux, F., Tillement, O., Roulin, C., Dutreix, M., Bechet, D., Huger, S., Humbert, L., Barberi-Heyob, M., Aloy, M. T., Armandy, E., Rodriguez-Lafrasse, C., Le Duc, G., Roux, S., and Perriat, P. (2011) In vitro radiosensitizing effects of ultrasmall gadolinium based particles on tumour cells J. Nanosci. Nanotechnol. 11, 7833-7839
37. Choi, H. S., Liu, W., Liu, F., Nasr, K., Misra, P., Bawendi, M. G., and Frangioni, J. V. (2010) Design consideration for tumour-targeted nanoparticles Nat. Nanotechnol. 5, 42-47
38. Bianchi, A., Lux, F., Tillement, O., and Crémillieux, Y. (2013) Contrast enhanced lung MRI in mice using ultra-short echo time radial imaging and intratracheally administrated Gd-DOTA-based nanoparticles Magn. Reson. Med. 10.1002/mrm.24580
39. Mignot, A., Truillet, C., Lux, F., Sancey, L., Louis, C., Denat, F., Boschetti, F., Bocher, L., Gloter, A., Stephan, O., Antoine, R., Dugourd, P., Luneau, D., Novitchi, G., Figueiredo, L. C., De Morais, P. C., Bonneviot, L., Albela, B., Ribot, F., Van Lokeren, L., Dechamps-Olivier, I., Chuburu, F., Lemercier, G., Villiers, C., Marche, P. N., Le Duc, G., Roux, S., Tillement, O., and Perriat, P. (2013) A top-down synthesis route to ultrasmall multifunctionnal Gd-based silica nanoparticles for theranostic applications Chem.-Eur. J. 19, 6122-6139
40. 177Lu SPECT imaging as a tool in molecular imaging tracer design Contrast Media Mol. Imaging 7, 214-222
41. Braiman, M. S., Briercheck, D. M., and Kriger, K. M. (1999) Modeling vibrationnal spectra of amino acids in proteins. III. Effects of protonation state, Counterion, and solvent on arginine C-N stretch frequencies J. Phys. Chem. 103, 4744-4750 (Pubitemid 129702642)
42. Morales-Avila, E., Ferro-Flores, G., Ocampo-Garcia, B. E., De Leon-Rodriguez, L. M., Santos-Cuevas, C. L., Garcia-Becerra, R., Medina, L. A., and Gomez-Olivan, L. (2011) Multimeric system of 99m Tc-labeled gold nanoparticles to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression Bioconjugate Chem. 22, 913-922
43. Hagen, J. J. and Monning, C. A. (1994) Method for estimating molecular mass from electrospray spectra Anal. Chem. 66, 1877-1883
44. Lawaetz, A. J. and Stedmon, C. A. (2009) Fluorescence intensity calibration using the raman scatter peak of water Appl. Spectrosc. 63, 936-940
45. Kafka, A. P., Rades, T., and McDowell, A. (2010) Rapid and specific high-performance liquid chromatography for the in vitro quantification of D-Lys6-GnRH in a microemulsion-type formulation in the presence of peptide oxidation products Biomed. Chromatogr. 24, 132-139
46. Maheshwari, G., Brown, G., Lauffenburger, D. A., Wells, A., and Griffith, L. G. (2000) Cell adhesion and mobility depend on nanoscale RGD clustering J. Cell. Sci. 113, 1677-1686 (Pubitemid 30333117)
47. Mammen, M., Choi, S. K., and Whitesides, G. M. (1998) Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors Angew. Chem., Int. Ed. Engl. 37, 2754-2794 (Pubitemid 29008561)
48. Galibert, M., Sancey, L., Renaudet, O., Coll, J. L., Dumy, P., and Boturyn, D. (2010) Application of click-click chemistry to the synthesis of new multivalent RGD conjugates Org. Biomol. Chem. 8, 5133-5138
49. Sancey, L., Garanger, E., Foillard, S., Schoehn, G., Hurbin, A., Albiges-Rizo, C., Boturyn, D., Souchier, C., Grichine, A., Dumy, P., and Coll, J. L. (2009) Clustering and internalization of integrin alphavbeta3 with a tetrameric RGD-synthetic peptide Mol. Ther. 17, 837-843